When it comes to bringing an experimental drug to market and selling it, Novo Nordisk, maker of the weight loss drug Wegovy, is tops, according to a new analysis. #STATBreakthrough https://t.co/ud9F9dTHJe
Then @ideapharma will unveil a ranking of the top large pharmaceutical companies when it comes to invention and innovation -- two things that Mike will tell you are very different.
Created in partnership with @IDEAPharma, the CNS Summit Digital Innovation Index is our annual objective assessment of the investments being made to advance innovation in the #lifesciences industry.
Download the latest index here: https://t.co/0elfSgZprD
🏆 Today, we gathered at #cnssummit2023 to recognise excellence, innovation and a #biopharma company that has masterfully blended tradition with groundbreaking technological marvels. @Boehringer impressively claimed the third place in our Digital Innovation Index.
🏆On today's special occasion at #CNSSummit, we celebrated @AstraZeneca’s meteoric rise to the top spot in our Digital Innovation Index. It isn't just a numerical achievement; it's a testament to their visionary digital leaps & pioneering activities in the clinical arena.
“AstraZeneca’s been incredibly successful by ensuring our digital solutions focus on what’s most relevant and meaningful to patients as part of their treatment journey.”
- @AlicynCampbell of @AstraZeneca, winner of the #CNSSummit2023 Digital Innovation Index Award.
💯 and we should plan for bringing doctors and sites along on the journey to revolutionise clinical trials with #AI. They experience a massive tech burden of nonintegrated tools. #CNSSummit2023
“We believe AI will become the new language of biology, solving previously insurmountable problems, and transforming medicine from an art form into a predictive science.”
@charleskfisher of @UnlearnAI and @RoetKasper of @QurAlisCo on the promise of #digitaltwins. #CNSSummit2023
Tarek Rabah reflects on @OtsukaUS’ dedication to finding unconventional solutions for complex, underserved medical needs:
“We must look beyond our own clinical pipelines to collaborate with others who may bring entirely new expertise and mindsets to the table.”
#CNSSummit2023
Too soon for a verdict on #AI designed drugs... failure is an inevitable part of #innovation. It doesn't mean failing more often would lead to innovation, but learning most likely will. #biopharma innovators @exscientiaAI @RecursionPharma create change.
https://t.co/UE4vz1NAc6
I’m honored to be a part of the lineup at #CNSSummit2023! Join me as I discuss #biopharma digital trends over the last year as well as a comprehensive look at our industry's leading digital innovators. I’m looking forward to connecting with everyone in Boston @CNSSummit!